Edition:
United States

INSYS Therapeutics Inc (INSY.OQ)

INSY.OQ on NASDAQ Stock Exchange Global Market

4.66USD
3:59pm EST
Change (% chg)

$0.35 (+8.12%)
Prev Close
$4.31
Open
$4.32
Day's High
$4.73
Day's Low
$4.32
Volume
156,095
Avg. Vol
129,972
52-wk High
$11.64
52-wk Low
$3.35

Select another date:

Scope of opioid epidemic may complicate jury selection for Insys trial

Jury selection began on Thursday in the trial of five former executives of opioid maker Insys Therapeutics Inc, as potential jurors were questioned about whether they have been affected by the opioid epidemic.

Ex-Insys sales director loses bid for separate opioid bribe trial

An ex-regional sales director at Insys Therapeutics Inc on Thursday lost her bid to avoid being tried alongside four other of the drugmaker's former executives and managers accused of conspiring to pay doctors bribes in exchange for prescribing an addictive opioid.

Former Insys CEO pleads guilty to opioid kickback scheme

BOSTON The former chief executive of Insys Therapeutics Inc pleaded guilty on Wednesday to participating in a nationwide scheme to bribe doctors to prescribe an addictive opioid medication and has agreed to become a government witness.

UPDATE 2-Former Insys CEO pleads guilty to opioid kickback scheme

BOSTON, Jan 9 The former chief executive of Insys Therapeutics Inc pleaded guilty on Wednesday to participating in a nationwide scheme to bribe doctors to prescribe an addictive opioid medication and has agreed to become a government witness.

Former Insys CEO to plead guilty in opioid kickback case

BOSTON, Jan 9 The former chief executive of Insys Therapeutics Inc is expected on Wednesday to plead guilty to participating in a scheme to pay doctors bribes in exchange for prescribing an addictive opioid medication.

Ex-Insys CEO to plead guilty to opioid kickback scheme

BOSTON The former chief executive of Insys Therapeutics Inc has agreed to plead guilty to participating in a scheme to bribe doctors to prescribe a powerful opioid medication in order to boost its sales, U.S. prosecutors said on Wednesday.

UPDATE 2-Ex-Insys CEO to plead guilty to opioid kickback scheme

BOSTON, Dec 26 The former chief executive of Insys Therapeutics Inc has agreed to plead guilty to participating in a scheme to bribe doctors to prescribe a powerful opioid medication in order to boost its sales, U.S. prosecutors said on Wednesday.

Former Insys CEO to plead guilty to opioid kickback scheme

BOSTON, Dec 26 The former chief executive of Insys Therapeutics Inc has agreed to plead guilty to participating in a scheme to bribe doctors to prescribe a powerful opioid medication sold by the company, U.S. prosecutors said on Wednesday.

'60 Minutes' opioid whistleblower can testify at Insys trial - judge

Six former Insys Therapeutics Inc executives and managers accused of bribing doctors to prescribe an opioid have lost an effort to prevent an ex-DEA official who has called for locking up opioid company executives from testifying at their trial.

Feds push to call '60 Minutes' opioid whistleblower at Insys trial

Prosecutors are fighting a bid by several Insys Therapeutics Inc executives, who have been accused of bribing doctors to prescribe its opioid spray, to prevent an ex-DEA official who has called for locking up opioid company executives from testifying at their trial.

Select another date: